Roberts Zachary sold ALLO

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001851044-26-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

Jan 21, 2026

Published

Jan 23, 2026

Ingested by INSIDER

Nov 5, 04:21 UTC

Last re-read

Nov 5, 04:21 UTC

Extracted facts

Filer

Roberts Zachary

Role

EVP of R&D

Transaction

Open-market saleAs filed: “S”

Asset

Allogene Therapeutics, Inc.

Ticker

ALLO

Shares

26.3K

Price per share

$1.56

Value

$40,980

Execution date (reported)

Jan 21, 2026

Owned after transaction

616.9K shares

Days from execution to publication

2

Calculation

What this establishes

Roberts Zachary filed this Form 4 reporting a open-market sale of ALLO on Jan 21, 2026. It became public on Jan 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

EVP of R&D

Roberts Zacharycik:0001851044

Issuer

Allogene Therapeutics, Inc.cik:0001737287

Revision history · 0

No field has changed since this record was first ingested.